NPI: 1083678320 · ALEXANDRIA, VA 22304 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/13/2006
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/13/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,800 | $566K |
| 2019 | 19,630 | $330K |
| 2020 | 10,466 | $193K |
| 2021 | 8,627 | $145K |
| 2022 | 10,455 | $280K |
| 2023 | 4,200 | $278K |
| 2024 | 1,709 | $126K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 20,161 | 1,232 | $1.21M | |
| 90935 | 3,603 | 274 | $539K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,405 | 1,221 | $135K |
| J1756 | Injection, iron sucrose, 1 mg | 5,948 | 1,225 | $17K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 532 | 251 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,590 | 1,060 | $3K |
| A4657 | Syringe, with or without needle, each | 3,000 | 1,005 | $2K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 117 | 30 | $82.55 |
| 83970 | 403 | 224 | $78.06 | |
| 82728 | 370 | 217 | $29.04 | |
| 83550 | 514 | 307 | $26.97 | |
| 83540 | 512 | 306 | $19.64 | |
| 85041 | 833 | 487 | $15.75 | |
| 85048 | 830 | 487 | $13.64 | |
| 82108 | 51 | 32 | $1.70 | |
| 90674 | 18 | 13 | $1.40 |